Literature DB >> 17006934

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.

Raphael B Merriman1, Linda D Ferrell, Marco G Patti, Shiobhan R Weston, Mark S Pabst, Bradley E Aouizerat, Nathan M Bass.   

Abstract

In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies--right and left lobe--in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty-one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single-sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 17006934     DOI: 10.1002/hep.21346

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  89 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 3.  Nonalcoholic fatty liver disease.

Authors:  Sandra K Erickson
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

4.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

5.  Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.

Authors:  Veeral H Ajmera; Amy Liu; Seema Singh; Georg Yachoa; Matthew Ramey; Meera Bhargava; Ava Zamani; Scarlett Lopez; Neeraj Mangla; Ricki Bettencourt; Emily Rizo; Mark Valasek; Cynthia Behling; Lisa Richards; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2020-01-27       Impact factor: 17.425

Review 6.  Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.

Authors:  Steven D Lidofsky
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver.

Authors:  Susan M Noworolski; Phyllis C Tien; Raphael Merriman; Daniel B Vigneron; Aliya Qayyum
Journal:  Magn Reson Imaging       Date:  2008-11-06       Impact factor: 2.546

8.  Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.

Authors:  Goutam Ghoshal; Roberto J Lavarello; Jeremy P Kemmerer; Rita J Miller; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2012-10-11       Impact factor: 2.998

9.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

10.  Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

Authors:  Antonio Ramos-De la Medina; José M Remes-Troche; Federico B Roesch-Dietlen; Alfonso G Pérez-Morales; Silvia Martinez; Silvia Cid-Juarez
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.